Study Shows Limited Utility Of OpenAI’s GPT-4 In Bioweapon Development Study Shows Limited Utility Of OpenAI’s GPT-4 In Bioweapon Development

Photo of author

By Ronald Tech

OpenAI Investigates GPT-4’s Potential for Bioweapon Development

OpenAI’s latest artificial intelligence offering, GPT-4, has been put to the test in a study that revealed its minimal ability to assist in the production of biological threats.

Studying GPT-4’s Risk of Contributing to Harmful Purposes

Amid concerns raised by legislators and industry leaders, OpenAI conducted tests to assess the potential risks of its AI model being exploited for the creation of biological weapons.

Government Mandate Spurs OpenAI’s Preparedness Team

Following an executive order from President Joe Biden, OpenAI formed a “preparedness” team to address potential risks associated with AI technologies, focusing on chemical, biological, and nuclear threats.

Study Reveals Limited Efficacy of GPT-4 for Threat Creation

OpenAI’s research involved 50 biology experts and 50 college-level biology students, concluding that the use of GPT-4 marginally improves the acquisition of information for creating biological threats.

Growing Concerns Over AI’s Potential Misuse

The study reflects increasing concern over the potential misuse of AI tools, prompting initiatives by OpenAI CEO Sam Altman to address fears regarding AI’s dual-use potential.

Expert Warnings and Future Studies

Beyond the study, experts have warned about the potential for AI, including GPT-4, to facilitate the creation of malware programs and cybersecurity threats, leading to ongoing research into AI’s role in cybersecurity threats and personal belief influence.

Photo Courtesy: Shutterstock.com


See also  Top Momentum Stocks to Watch Best Momentum Stocks to Buy for February 9th